The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of sequential ipilimumab in the definitive treatment of node positive cervical cancer: GOG 9929.
 
Jyoti Mayadev
No Relationships to Disclose
 
William E. Brady
Consulting or Advisory Role - Ultragenyx Pharmaceuticals
Research Funding - Nektar (Inst)
 
Yvonne Gail Lin
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Consulting or Advisory Role - ClearPath Development Company
Research Funding - Array BioPharma; Astex Pharmaceuticals
 
Diane M Da Silva
No Relationships to Disclose
 
Heather A. Lankes
No Relationships to Disclose
 
Paula M. Fracasso
Employment - Bristol-Myers Squibb
Other Relationship - Bristol-Myers Squibb
 
Sharad A. Ghamande
Research Funding - advaxis
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunogen (Inst); TESARO (Inst); VBL Therapeutics (Inst)
Travel, Accommodations, Expenses - Novocure; Takeda Milenium
 
Huyen Q. Pham
No Relationships to Disclose
 
Kelly Jeanes Wilkinson
No Relationships to Disclose
 
Vanessa Amy Kennedy
No Relationships to Disclose
 
Carol Aghajanian
Consulting or Advisory Role - Bayer; Cerulean Pharma; Cerulean Pharma; Oxigene; VentiRx
 
Wui-Jin Koh
No Relationships to Disclose
 
Bradley J. Monk
Consulting or Advisory Role - Advaxis; Amgen; AstraZeneca; Bayer; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Insys Therapeutics; Merck; Nucana; Oxigene; Pfizer; Roche/Genentech; Tesaro; Verastem; Vermillion
Speakers' Bureau - AstraZeneca; Janssen; Myriad Genetics; Roche/Genentech
Research Funding - Amgen (Inst); Array BioPharma (Inst); Genentech (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Tesaro (Inst)
 
Russell J. Schilder
Consulting or Advisory Role - Celsion; Clovis Oncology; Merrimack